Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer

被引:84
作者
Lange, Carol A. [1 ]
Gioeli, Daniel
Hammes, Stephen R.
Marker, Paul C.
机构
[1] Univ Virginia Hlth Syst, Dept Med, Div Hemtol Oncol & Transplant & Pharmacol, Charlottesville, VA 22908 USA
[2] Univ Virginia Hlth Syst, Dept Microbiol, Charlottesville, VA 22908 USA
[3] Univ Texas, SW Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Dallas, TX 75230 USA
[4] Univ Minnesota, Ctr Canc, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA
关键词
progesterone receptor; androgen receptor; epidermal growth factor; mitogen-activated protein kinase; cyclin D1;
D O I
10.1146/annurev.physiol.69.031905.160319
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Steroid hormone receptors (SRs) are ligand-activated transcription factors and sensors for growth factor-initiated signaling pathways in hormonally regulated tissues, such as the breast or prostate. Recent discoveries suggest that several protein kinases are rapidly activated in response to steroid hormone binding to cytoplasmic SRs. Induction of rapid signaling upon SR ligand binding ensures that receptors and coregulators are appropriately phosphorylated as part of optimal transcription complexes. Alternatively, SR-activated kinase cascades provide additional avenues for SR-regulated gene expression independent of SR nuclear action. We provide an overview of SR and signaling cross talk in breast and prostate cancers, using the human progesterone receptor (PR) and androgen receptor (AR) as models. Kinases are emerging as key mediators of SR action. Cross talk between SR and membrane-initiated signaling events suggests a mechanism for coordinate regulation of gene subsets by mitogenic stimuli in hormonally responsive normal tissues; such cross talk is suspected to contribute to cancer biology.
引用
收藏
页码:171 / 199
页数:29
相关论文
共 156 条
[1]   Prostate cancer cell cycle regulators: Response to androgen withdrawal and development of androgen independence [J].
Agus, DB ;
Cordon-Cardo, C ;
Fox, W ;
Drobnjak, M ;
Koff, A ;
Golde, DW ;
Scher, HI .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (21) :1869-1876
[2]   Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth [J].
Agus, DB ;
Akita, RW ;
Fox, WD ;
Lewis, GD ;
Higgins, B ;
Pisacane, PI ;
Lofgren, JA ;
Tindell, C ;
Evans, DP ;
Maiese, K ;
Scher, HI ;
Sliwkowski, MX .
CANCER CELL, 2002, 2 (02) :127-137
[3]   TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS [J].
ALBANESE, C ;
JOHNSON, J ;
WATANABE, G ;
EKLUND, N ;
VU, D ;
ARNOLD, A ;
PESTELL, RG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23589-23597
[4]   MODULATION OF TRANSCRIPTIONAL ACTIVATION BY LIGAND-DEPENDENT PHOSPHORYLATION OF THE HUMAN ESTROGEN RECEPTOR-A/B REGION [J].
ALI, S ;
METZGER, D ;
BORNERT, JM ;
CHAMBON, P .
EMBO JOURNAL, 1993, 12 (03) :1153-1160
[5]  
Altucci L, 1996, ONCOGENE, V12, P2315
[6]  
Ankrapp DP, 1998, J CELL PHYSIOL, V174, P251, DOI 10.1002/(SICI)1097-4652(199802)174:2<251::AID-JCP12>3.0.CO
[7]  
2-F
[8]   Progesterone receptor isoforms A and B: Temporal and spatial differences in expression during murine mammary gland development [J].
Aupperlee, MD ;
Smith, KT ;
Kariagina, A ;
Haslam, SZ .
ENDOCRINOLOGY, 2005, 146 (08) :3577-3588
[9]  
Bakin RE, 2003, CANCER RES, V63, P1975
[10]   Two domains of the progesterone receptor interact with the estrogen receptor and are required for progesterone activation of the c-Src/Erk pathway in mammalian cells [J].
Ballaré, C ;
Uhrig, M ;
Bechtold, T ;
Sancho, E ;
Di Domenico, M ;
Migliaccio, A ;
Auricchio, F ;
Beato, M .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :1994-2008